Active Juvenile Idiopathic Arthritis (JIA)Compassionate Use
Status: | Archived |
---|---|
Conditions: | Arthritis |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | Any |
Updated: | 7/1/2011 |
Start Date: | March 2009 |
End Date: | February 2014 |
Compassionate Use Study of Adalimumab in Children 2 to < 4 Years Old or Age 4 and Above Weighing Less Than 15 kg With Active Juvenile Idiopathic Arthritis (JIA)
The purpose of this research study is to determine if adalimumab is safe and effective in
the treatment of patients with JIA who are 2 to <4 years old or age 4 and above weighing
less than 15kg.
New sites are regularly recruiting patients. Please contact Abbott personnel for more
information regarding any of the sites associated with this trial.
We found this trial at
23
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials